Preventive effects of Suvorexant on delirium at postoperative hip surgery: arandomized placebo-controlled trial

Preventive effects of Suvorexant on delirium at postoperative hip surgery: arandomized placebo-controlled trial - Suvorexant prevents delirium in postoperative hip surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024269

Enrollment

100

Registered

2016-10-03

Start date

2016-10-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip surgery patiens

Interventions

to recieve suvorexants placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: elective hip surgery patients

Exclusion criteria

Exclusion criteria: dementia SAS the patients not agree severe disorder of liver function

Design outcomes

Primary

Measure	Time frame
Incidence of delirium	—

Countries

Japan

Contacts

Public ContactManabu Yoshimura

Japan Community Healthcare Organization Tokuyama Central Hospital Anesthesiology

manabu-ygc@umin.ac.jp0834-22-4411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026